Literature DB >> 23602659

Molecular basis of sphingosine kinase 1 substrate recognition and catalysis.

Zhulun Wang1, Xiaoshan Min, Shou-Hua Xiao, Sheree Johnstone, William Romanow, David Meininger, Haoda Xu, Jinsong Liu, Jessica Dai, Songzhu An, Stephen Thibault, Nigel Walker.   

Abstract

Sphingosine kinase 1 (SphK1) is a lipid kinase that catalyzes the conversion of sphingosine to sphingosine-1-phosphate (S1P), which has been shown to play a role in lymphocyte trafficking, angiogenesis, and response to apoptotic stimuli. As a central enzyme in modulating the S1P levels in cells, SphK1 emerges as an important regulator for diverse cellular functions and a potential target for drug discovery. Here, we present the crystal structures of human SphK1 in the apo form and in complexes with a substrate sphingosine-like lipid, ADP, and an inhibitor at 2.0-2.3 Å resolution. The SphK1 structures reveal a two-domain architecture in which its catalytic site is located in the cleft between the two domains and a hydrophobic lipid-binding pocket is buried in the C-terminal domain. Comparative analysis of these structures with mutagenesis and kinetic studies provides insight into how SphK1 recognizes the lipid substrate and catalyzes ATP-dependent phosphorylation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602659     DOI: 10.1016/j.str.2013.02.025

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  69 in total

1.  Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.

Authors:  Elizabeth S Childress; Yugesh Kharel; Anne M Brown; David R Bevan; Kevin R Lynch; Webster L Santos
Journal:  J Med Chem       Date:  2017-04-25       Impact factor: 7.446

Review 2.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

3.  Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells.

Authors:  Hoe-Sup Byun; Susan Pyne; Neil Macritchie; Nigel J Pyne; Robert Bittman
Journal:  Medchemcomm       Date:  2013       Impact factor: 3.597

Review 4.  Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.

Authors:  Gregory T Kunkel; Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  Nat Rev Drug Discov       Date:  2013-08-19       Impact factor: 84.694

5.  Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.

Authors:  Neeraj N Patwardhan; Emily A Morris; Yugesh Kharel; Mithun R Raje; Ming Gao; Jose L Tomsig; Kevin R Lynch; Webster L Santos
Journal:  J Med Chem       Date:  2015-02-13       Impact factor: 7.446

Review 6.  Leukocyte driven-decidual angiogenesis in early pregnancy.

Authors:  Patricia D A Lima; Jianhong Zhang; Caroline Dunk; Stephen J Lye; B Anne Croy
Journal:  Cell Mol Immunol       Date:  2014-07-28       Impact factor: 11.530

7.  Targeting sphingosine kinase 1 in acute myeloid leukemia: translation to clinic.

Authors:  Jason A Powell; Craig T Wallington-Beddoe; Stuart M Pitson
Journal:  Int J Hematol Oncol       Date:  2017-07-18

Review 8.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

9.  Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles.

Authors:  Joseph D Houck; Thomas K Dawson; Andrew J Kennedy; Yugesh Kharel; Niels D Naimon; Saundra D Field; Kevin R Lynch; Timothy L Macdonald
Journal:  ACS Med Chem Lett       Date:  2016-03-01       Impact factor: 4.345

Review 10.  Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.

Authors:  C Evangelisti; C Evangelisti; F Buontempo; A Lonetti; E Orsini; F Chiarini; J T Barata; S Pyne; N J Pyne; A M Martelli
Journal:  Leukemia       Date:  2016-07-27       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.